Literature DB >> 21706042

Tyrosine sulfation in N-terminal domain of human C5a receptor is necessary for binding of chemotaxis inhibitory protein of Staphylococcus aureus.

Zhen-jia Liu1, Yan-juan Yang, Lei Jiang, Ying-chun Xu, Ai-xia Wang, Guan-hua Du, Jin-ming Gao.   

Abstract

AIM: Staphylococcus aureus evades host defense through releasing several virulence proteins, such as chemotaxis inhibitory protein of staphylococcus aureus (CHIPS). It has been shown that extracellular N terminus of C5a receptor (C5aR) forms the binding domain for CHIPS, and tyrosine sulfation is emerging as a key factor in determining protein-protein interaction. The aim of this study was to evaluate the role of tyrosine sulfation of N-terminal of C5aR in its binding with CHIPS.
METHODS: Expression plasmids encoding C5aR and its mutants were prepared using PCR and site-directed mutagenesis and were used to transfect HEK 293T cells using calcium phosphate. Recombinant CHIPS protein was purified. Western blotting was used to examine the binding efficiency of CHIPS to C5aR or its mutants.
RESULTS: CHIPS exclusively binds to C5aR, but not to C5L2 or C3aR. A nonspecific sulfation inhibitor, sodium chlorate (50 nmol/L), diminishes the binding ability of C5aR with CHIPS. Blocking sulfation by mutation of tyrosine to phenylalanine at positions 11 and 14 of C5aR N terminus, which blocked sulfation, completely abrogates CHIPS binding. When tyrosine 14 alone was mutated to phenylalanine, the binding efficiency of recombinant CHIPS was substantially decreased.
CONCLUSION: The results demonstrate a structural basis of C5aR-CHIPS association, in which tyrosine sulfation of N-terminal C5aR plays an important role. Our data may have potential significance in development of novel drugs for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21706042      PMCID: PMC4002527          DOI: 10.1038/aps.2011.53

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  35 in total

Review 1.  What is MRSA?

Authors:  A Pantosti; M Venditti
Journal:  Eur Respir J       Date:  2009-11       Impact factor: 16.671

2.  The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding.

Authors:  Anne-Marie Scola; Adrian Higginbottom; Lynda J Partridge; Robert C Reid; Trent Woodruff; Stephen M Taylor; David P Fairlie; Peter N Monk
Journal:  J Biol Chem       Date:  2006-12-11       Impact factor: 5.157

3.  Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus--an anti-inflammatory protein.

Authors:  Erika Gustafsson; Cecilia Forsberg; Karin Haraldsson; Stina Lindman; Lill Ljung; Christina Furebring
Journal:  Protein Expr Purif       Date:  2008-10-05       Impact factor: 1.650

4.  Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.

Authors:  Justin Liu; Samuel Louie; Willy Hsu; Kristine M Yu; Hugh B Nicholas; Grace L Rosenquist
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

5.  Chapter 7. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors.

Authors:  Hyeryun Choe; Michael Farzan
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

6.  Analysis of tyrosine-O-sulfation.

Authors:  Jens R Bundgaard; Jette W Sen; Anders H Johnsen; Jens F Rehfeld
Journal:  Methods Mol Biol       Date:  2008

7.  Structural models for the complex of chemotaxis inhibitory protein of Staphylococcus aureus with the C5a receptor.

Authors:  Gregory V Nikiforovich; Thomas J Baranski
Journal:  Biochem Biophys Res Commun       Date:  2009-09-30       Impact factor: 3.575

8.  Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10.

Authors:  Jin-Ming Gao; Ruo-Lan Xiang; Lei Jiang; Wen-Hui Li; Qi-Ping Feng; Zi-Jiang Guo; Qi Sun; Zheng-Pei Zeng; Fu-de Fang
Journal:  Acta Pharmacol Sin       Date:  2009-01-19       Impact factor: 6.150

9.  Structure of the tyrosine-sulfated C5a receptor N terminus in complex with chemotaxis inhibitory protein of Staphylococcus aureus.

Authors:  Johannes H Ippel; Carla J C de Haas; Anton Bunschoten; Jos A G van Strijp; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
Journal:  J Biol Chem       Date:  2009-02-27       Impact factor: 5.157

10.  Characterisation of receptor binding by the chemotaxis inhibitory protein of Staphylococcus aureus and the effects of the host immune response.

Authors:  Andrew J Wright; Adrian Higginbottom; Didier Philippe; Abhishek Upadhyay; Stefan Bagby; Robert C Read; Peter N Monk; Lynda J Partridge
Journal:  Mol Immunol       Date:  2007-01-26       Impact factor: 4.407

View more
  5 in total

Review 1.  The bicomponent pore-forming leucocidins of Staphylococcus aureus.

Authors:  Francis Alonzo; Victor J Torres
Journal:  Microbiol Mol Biol Rev       Date:  2014-06       Impact factor: 11.056

2.  IRAK-M Associates with Susceptibility to Adult-Onset Asthma and Promotes Chronic Airway Inflammation.

Authors:  Yi Liu; Mingqiang Zhang; Lili Lou; Lun Li; Youming Zhang; Wei Chen; Weixun Zhou; Yan Bai; Jinming Gao
Journal:  J Immunol       Date:  2019-01-07       Impact factor: 5.422

3.  Complement factor H, vitronectin, and opticin are tyrosine-sulfated proteins of the retinal pigment epithelium.

Authors:  Yogita Kanan; Joseph C Siefert; Michael Kinter; Muayyad R Al-Ubaidi
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

4.  Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model.

Authors:  Morag Rose Hunter; Natasha Lillia Grimsey; Michelle Glass
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

5.  Plant immunity: Rice XA21-mediated resistance to bacterial infection.

Authors:  María Florencia Ercoli; Dee Dee Luu; Ellen Youngsoo Rim; Alexandra Shigenaga; Artur Teixeira de Araujo; Mawsheng Chern; Rashmi Jain; Randy Ruan; Anna Joe; Valley Stewart; Pamela Ronald
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-22       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.